Papillary Renal Cell Carcinoma: Outcomes for Patients Receiving First-line Immune-based Combinations or Tyrosine Kinase Inhibitors from the ARON-1 Study

Francesco Massari, Veronica Mollica, Ondřej Fiala, Ugo De Giorgi, Jakub Kucharz, Maria Giuseppa Vitale, Javier Molina‐Cerrillo, Gaetano Facchini, Emmanuel Seront, Edoardo Lenci, María T. Bourlon, Francesco Carrozza, Renate Pichler, Cristian Lolli, Zin Myint, Ravindran Kanesvaran, Mariangela Torniai, Pasquale Rescigno, Alfonso Gomez de Liaño, Roubini Zakopoulou, Sebastiano Buti, Camillo Porta, Enrique Grande, Matteo Santoni